These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
277 related items for PubMed ID: 23431033
1. DNase inhibits Gardnerella vaginalis biofilms in vitro and in vivo. Hymes SR, Randis TM, Sun TY, Ratner AJ. J Infect Dis; 2013 May 15; 207(10):1491-7. PubMed ID: 23431033 [Abstract] [Full Text] [Related]
2. The biofilm in bacterial vaginosis: implications for epidemiology, diagnosis and treatment. Verstraelen H, Swidsinski A. Curr Opin Infect Dis; 2013 Feb 15; 26(1):86-9. PubMed ID: 23221767 [Abstract] [Full Text] [Related]
3. Lysozyme as a cotreatment during antibiotics use against vaginal infections: An in vitro study on Gardnerella vaginalis biofilm models. Thellin O, Zorzi W, Zorzi D, Delvenne P, Heinen E, ElMoualij B, Quatresooz P. Int Microbiol; 2016 Jun 15; 19(2):101-107. PubMed ID: 27845497 [Abstract] [Full Text] [Related]
4. Vaginal biofilms and bacterial vaginosis: of mice and women. Marrazzo JM. J Infect Dis; 2013 May 15; 207(10):1481-3. PubMed ID: 23431034 [No Abstract] [Full Text] [Related]
5. Screening of Compounds against Gardnerella vaginalis Biofilms. Gottschick C, Szafranski SP, Kunze B, Sztajer H, Masur C, Abels C, Wagner-Döbler I. PLoS One; 2016 May 15; 11(4):e0154086. PubMed ID: 27111438 [Abstract] [Full Text] [Related]
6. Gemini Cationic Amphiphiles Control Biofilm Formation by Bacterial Vaginosis Pathogens. Algburi A, Zhang Y, Weeks R, Comito N, Zehm S, Pinto J, Uhrich KE, Chikindas ML. Antimicrob Agents Chemother; 2017 Dec 15; 61(12):. PubMed ID: 28893789 [Abstract] [Full Text] [Related]
7. The association of Atopobium vaginae and Gardnerella vaginalis with bacterial vaginosis and recurrence after oral metronidazole therapy. Bradshaw CS, Tabrizi SN, Fairley CK, Morton AN, Rudland E, Garland SM. J Infect Dis; 2006 Sep 15; 194(6):828-36. PubMed ID: 16941351 [Abstract] [Full Text] [Related]
8. The Natural Antimicrobial Subtilosin A Synergizes with Lauramide Arginine Ethyl Ester (LAE), ε-Poly-L-lysine (Polylysine), Clindamycin Phosphate and Metronidazole, Against the Vaginal Pathogen Gardnerella vaginalis. Cavera VL, Volski A, Chikindas ML. Probiotics Antimicrob Proteins; 2015 Jun 15; 7(2):164-71. PubMed ID: 25588687 [Abstract] [Full Text] [Related]
9. Metatranscriptome Analysis of the Vaginal Microbiota Reveals Potential Mechanisms for Protection against Metronidazole in Bacterial Vaginosis. Deng ZL, Gottschick C, Bhuju S, Masur C, Abels C, Wagner-Döbler I. mSphere; 2018 Jun 27; 3(3):. PubMed ID: 29875146 [Abstract] [Full Text] [Related]
10. Response of Gardnerella vaginalis biofilm to 5 days of moxifloxacin treatment. Swidsinski A, Dörffel Y, Loening-Baucke V, Schilling J, Mendling W. FEMS Immunol Med Microbiol; 2011 Feb 27; 61(1):41-6. PubMed ID: 20955467 [Abstract] [Full Text] [Related]
11. [Antibiotic resistance of Gardnerella vaginalis isolated from cases of bacterial vaginosis]. Tomusiak A, Strus M, Heczko PB. Ginekol Pol; 2011 Dec 27; 82(12):900-4. PubMed ID: 22384625 [Abstract] [Full Text] [Related]
12. BV and non-BV associated Gardnerella vaginalis establish similar synergistic interactions with other BV-associated microorganisms in dual-species biofilms. Castro J, Cerca N. Anaerobe; 2015 Dec 27; 36():56-9. PubMed ID: 26505928 [Abstract] [Full Text] [Related]
13. Unveiling the role of Gardnerella vaginalis in polymicrobial Bacterial Vaginosis biofilms: the impact of other vaginal pathogens living as neighbors. Castro J, Machado D, Cerca N. ISME J; 2019 May 27; 13(5):1306-1317. PubMed ID: 30670827 [Abstract] [Full Text] [Related]
14. Using an in-vitro biofilm model to assess the virulence potential of bacterial vaginosis or non-bacterial vaginosis Gardnerella vaginalis isolates. Castro J, Alves P, Sousa C, Cereija T, França Â, Jefferson KK, Cerca N. Sci Rep; 2015 Jun 26; 5():11640. PubMed ID: 26113465 [Abstract] [Full Text] [Related]
15. Influence of Biofilm Formation by Gardnerella vaginalis and Other Anaerobes on Bacterial Vaginosis. Machado A, Cerca N. J Infect Dis; 2015 Dec 15; 212(12):1856-61. PubMed ID: 26080369 [Abstract] [Full Text] [Related]
16. Treatment failure of bacterial vaginosis is not associated with higher loads of Atopobium vaginae and Gardnerella vaginalis. Ferreira CST, Donders GG, Parada CMGL, Tristão ADR, Fernandes T, da Silva MG, Marconi C. J Med Microbiol; 2017 Aug 15; 66(8):1217-1224. PubMed ID: 28792372 [Abstract] [Full Text] [Related]
17. Saccharomyces cerevisiae-based probiotic as novel anti-microbial agent for therapy of bacterial vaginosis. Sabbatini S, Monari C, Ballet N, Mosci P, Decherf AC, Pélerin F, Perito S, Scarpelli P, Vecchiarelli A. Virulence; 2018 Dec 31; 9(1):954-966. PubMed ID: 29683763 [Abstract] [Full Text] [Related]
18. Gardnerella vaginalis outcompetes 29 other bacterial species isolated from patients with bacterial vaginosis, using in an in vitro biofilm formation model. Alves P, Castro J, Sousa C, Cereija TB, Cerca N. J Infect Dis; 2014 Aug 15; 210(4):593-6. PubMed ID: 24596283 [Abstract] [Full Text] [Related]
19. Current Treatment of Bacterial Vaginosis-Limitations and Need for Innovation. Bradshaw CS, Sobel JD. J Infect Dis; 2016 Aug 15; 214 Suppl 1(Suppl 1):S14-20. PubMed ID: 27449869 [Abstract] [Full Text] [Related]
20. Impact of oral metronidazole treatment on the vaginal microbiota and correlates of treatment failure. Verwijs MC, Agaba SK, Darby AC, van de Wijgert JHHM. Am J Obstet Gynecol; 2020 Feb 15; 222(2):157.e1-157.e13. PubMed ID: 31404542 [Abstract] [Full Text] [Related] Page: [Next] [New Search]